⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 2, 2024Open Access

Supplementary Figure S5 from Cereblon-based Bifunctional Degrader of SOS1, BTX-6654, Targets Multiple KRAS Mutations and Inhibits Tumor Growth

Kyle Begovich Angela Schoolmeesters Navin Rajapakse Elena Martínez‐Terroba Maneesh Kumar Arvind Shakya Chon Lai Steven Greene Brandon Whitefield Akinori Okano Venkat Mali Shenlin Huang Aparajita H. Chourasia Leah Fung

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplementary Figure S5 demonstrates the synergistic effects of combining BTX-7312 with inhibitors of the RTK-RAS-MAPK pathway

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Begovich et al. (2024) studied this question.

synapsesocial.com/papers/68e70c4bb6db643587685e87 https://doi.org/10.1158/1535-7163.25523396

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S5 from Cereblon-based Bifunctional Degrader of SOS1, BTX-6654, Targets Multiple <i>KRAS</i> Mutations and Inhibits Tumor Growth2024
2Supplementary Figure S2 from Cereblon-based Bifunctional Degrader of SOS1, BTX-6654, Targets Multiple <i>KRAS</i> Mutations and Inhibits Tumor Growth2024
3Supplementary Figure S2 from Cereblon-based Bifunctional Degrader of SOS1, BTX-6654, Targets Multiple <i>KRAS</i> Mutations and Inhibits Tumor Growth2024
4Supplementary Figure S1 from Cereblon-based Bifunctional Degrader of SOS1, BTX-6654, Targets Multiple <i>KRAS</i> Mutations and Inhibits Tumor Growth2024
5Supplementary Figure S1 from Cereblon-based Bifunctional Degrader of SOS1, BTX-6654, Targets Multiple <i>KRAS</i> Mutations and Inhibits Tumor Growth2024

More related papers

Supplementary Figure S4 from Cereblon-based Bifunctional Degrader of SOS1, BTX-6654, Targets Multiple <i>KRAS</i> Mutations and Inhibits Tumor Growth2024
Supplementary Figure S4 from Cereblon-based Bifunctional Degrader of SOS1, BTX-6654, Targets Multiple <i>KRAS</i> Mutations and Inhibits Tumor Growth2024
Supplementary Methods from Cereblon-based Bifunctional Degrader of SOS1, BTX-6654, Targets Multiple <i>KRAS</i> Mutations and Inhibits Tumor Growth2024